ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.432C>T (p.Ser144=)

dbSNP: rs1046304919
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001082030 SCV000561530 likely benign Hereditary nonpolyposis colorectal neoplasms 2024-01-03 criteria provided, single submitter clinical testing
Ambry Genetics RCV000491454 SCV000580243 likely benign Hereditary cancer-predisposing syndrome 2016-05-13 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
GeneDx RCV000521132 SCV000618507 uncertain significance not provided 2017-05-31 criteria provided, single submitter clinical testing This variant is denoted MSH6 c.432C>T at the DNA level. Although this variant is silent at the coding level, preserving a Serine at codon 144, it is predicted to cause abnormal splicing. However, in the absence of RNA or functional studies, the actual effect of this variant is unknown. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. MSH6 c.432C>T was not observed in large population cohorts (NHLBI Exome Sequencing Project, The 1000 Genomes Consortium 2015, Lek 2016). The nucleotide which is altered, a cytosine (C) at base 432, is not conserved. Based on currently available information, it is unclear whether MSH6 c.432C>T is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Color Diagnostics, LLC DBA Color Health RCV000491454 SCV001348045 likely benign Hereditary cancer-predisposing syndrome 2019-06-10 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000521132 SCV004011160 likely benign not provided 2023-04-01 criteria provided, single submitter clinical testing MSH6: BP4, BP7
All of Us Research Program, National Institutes of Health RCV004002173 SCV004829220 likely benign Lynch syndrome 2023-06-28 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001355486 SCV001550388 uncertain significance Malignant tumor of breast no assertion criteria provided clinical testing The MSH6 p.Ser144= variant was not identified in the literature nor was it identified in the GeneInsight-COGR, Cosmic, UMD-LSDB, Zhejiang University, Mismatch Repair Genes Variant Database, MMR Gene Unclassified Variants Database, or Insight Hereditary Tumors databases. The variant was identified in dbSNP (ID: rs1046304919) as "With Likely benign allele", and in ClinVar (classified as likely benign by Invite and Ambry Genetics; as uncertain significance by GeneDx). The variant was identified in control databases in 1 of 246240 chromosomes at a frequency of 0.000004 (Genome Aggregation Database Feb 27, 2017). The variant was identified in the European population in 1 of 111692 chromosomes (freq: 0.00001), while the variant was not observed in the African, Other, Latino, Ashkenazi Jewish, East Asian, Finnish, and South Asian populations. The p.Ser144= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. The variant occurs outside of the splicing consensus sequence and 3 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing. However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.